Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry
Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the Safeheart registry
Learn more



